THÉRAPIES DE COMBINAISON PAR ANTICORPS ANTI-C35 ET PROCÉDÉS

• 收藏
• 分享

专利权人:

VACCINEX; INC.

发明人:

ZAUDERER, MAURICE,EVANS, ELIZABETH, E.

申请号：

EP08865503

公开号：

EP2237792A4

申请日:

2008.12.23

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The present invention is directed to methods of killing cancer cells, the methods comprising administering at least one C35 antibody and either at least one HER2 or at least one EGFR antibody. In some embodiments, the antibodies are administered with a therapeutic agent. The present invention is further directed to C35, HER2 and EGFR antibodies useful in these methods.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/